Skip to content
Governance Register

← US public companies

Corbus Pharmaceuticals Holdings, Inc.

SEC CIK 1595097 · CRBP · last insider filing 2026-06-11

Directors (from insider filings)

NameCapacity as filedFilings
Kung Winston Director filed 2024 - 2026
Jenkins John Kenneth Director filed 2018 - 2026
Altmeyer Anne Director filed 2022 - 2026
Jacques Rachelle Suzanne Director filed 2019 - 2026
Ben Yong Director filed 2023 - 2026
Pfeiffenberger Brent Director filed 2026 - 2026
Cohen Yuval Director · Chief Executive Officer filed 2014 - 2026
Holmer Alan F Director filed 2014 - 2025
Catlin Avery W Director filed 2014 - 2024
Salzmann Peter Director filed 2020 - 2024
Golumbeski George Director filed 2020 - 2020
Hochman David P Director filed 2014 - 2020
Panayiotopoulos Paris Director filed 2017 - 2019
Gupta Renu Director filed 2014 - 2017

Officers (from insider filings)

NameTitle as filedFilings
Saxena Nishant C Chief Business Officer filed 2026 - 2026
Smethurst Dominic Chief Medical Officer filed 2024 - 2026
Moran Sean F. Chief Financial Officer filed 2014 - 2026
Hodgson Ian Chief Operating Officer filed 2025 - 2026
Millian Craig Stuart Chief Operating Officer filed 2019 - 2023
Brake Rachael Louise Chief Scientific Officer filed 2021 - 2023
White Barbara Chief Medical Officer filed 2014 - 2021
Discordia Robert Paul Chief Operating Officer filed 2019 - 2020
Tepper Mark President and CSO filed 2014 - 2019

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.